Natixis Advisors L.P. Increases Stake in Ventas, Inc. (NYSE:VTR)

Natixis Advisors L.P. boosted its holdings in Ventas, Inc. (NYSE:VTR) by 29.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 24,273 shares of the real estate investment trust’s stock after acquiring an additional 5,540 shares during the quarter. Natixis Advisors L.P.’s holdings in Ventas were worth $1,422,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. JPMorgan Chase & Co. lifted its stake in Ventas by 22.6% during the third quarter. JPMorgan Chase & Co. now owns 7,214,027 shares of the real estate investment trust’s stock worth $392,299,000 after purchasing an additional 1,331,028 shares during the last quarter. Candriam Luxembourg S.C.A. lifted its stake in Ventas by 8.5% during the third quarter. Candriam Luxembourg S.C.A. now owns 27,533 shares of the real estate investment trust’s stock worth $1,497,000 after purchasing an additional 2,159 shares during the last quarter. Prudential Financial Inc. lifted its stake in Ventas by 2.1% during the third quarter. Prudential Financial Inc. now owns 545,181 shares of the real estate investment trust’s stock worth $29,647,000 after purchasing an additional 10,970 shares during the last quarter. AXA lifted its stake in Ventas by 9.0% during the third quarter. AXA now owns 70,241 shares of the real estate investment trust’s stock worth $3,819,000 after purchasing an additional 5,805 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its stake in Ventas by 1.8% during the third quarter. Janus Henderson Group PLC now owns 120,335 shares of the real estate investment trust’s stock worth $6,544,000 after purchasing an additional 2,178 shares during the last quarter. 88.49% of the stock is currently owned by institutional investors and hedge funds.

Several research analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Ventas from a “hold” rating to a “sell” rating in a report on Monday, December 31st. Deutsche Bank increased their price target on Ventas from $54.00 to $57.00 and gave the stock a “hold” rating in a report on Friday, March 29th. BMO Capital Markets increased their price objective on shares of Ventas from $60.00 to $62.00 and gave the stock a “market perform” rating in a research report on Monday, February 11th. Morgan Stanley assumed coverage on shares of Ventas in a research report on Thursday, March 28th. They set an “equal weight” rating and a $61.00 target price on the stock. Finally, KeyCorp set a $55.00 price target on shares of Ventas and gave the stock a “sell” rating in a research note on Thursday, December 20th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $59.33.

In other news, CFO Robert F. Probst sold 10,000 shares of the company’s stock in a transaction on Friday, February 15th. The shares were sold at an average price of $65.01, for a total transaction of $650,100.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Debra A. Cafaro sold 68,084 shares of the company’s stock in a transaction dated Wednesday, February 13th. The shares were sold at an average price of $64.09, for a total transaction of $4,363,503.56. Following the completion of the sale, the chairman now directly owns 805,835 shares of the company’s stock, valued at approximately $51,645,965.15. The disclosure for this sale can be found here. Over the last quarter, insiders sold 107,464 shares of company stock valued at $6,900,138. Company insiders own 1.40% of the company’s stock.

VTR traded up $0.07 during trading on Monday, hitting $62.10. 1,322,200 shares of the company traded hands, compared to its average volume of 2,066,286. The stock has a market capitalization of $22.09 billion, a price-to-earnings ratio of 15.26, a PEG ratio of 8.55 and a beta of 0.32. The company has a debt-to-equity ratio of 1.04, a quick ratio of 0.53 and a current ratio of 0.53. Ventas, Inc. has a 1 year low of $46.55 and a 1 year high of $65.70.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Friday, February 8th. The real estate investment trust reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.01. The company had revenue of $923.26 million during the quarter, compared to analyst estimates of $913.92 million. Ventas had a net margin of 10.93% and a return on equity of 3.54%. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter last year, the business posted $1.03 EPS. On average, equities research analysts forecast that Ventas, Inc. will post 3.81 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Monday, April 1st were paid a $0.7925 dividend. This represents a $3.17 annualized dividend and a dividend yield of 5.10%. The ex-dividend date was Friday, March 29th. Ventas’s dividend payout ratio is currently 77.89%.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this report on another publication, it was illegally copied and republished in violation of U.S. & international copyright law. The original version of this report can be read at https://www.baseballdailydigest.com/news/2019/04/15/ventas-inc-vtr-holdings-lifted-by-natixis-advisors-l-p.html.

Ventas Company Profile

Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.

Featured Story: Trading Ex-Dividend Strategy

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.